The traditional pharmaceutical R&D model grants periods of market exclusivity to incentivize investment in new therapies, but high drug prices can limit affordability and patient access
It's a type of neuropathic pain caused by nerve dysfunction where normal sensory signals become distorted
Authors relationships and activities SDP declares grants from AstraZeneca and Boehringer Ingelheim, consulting fees from Applied Therapeutics, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharpe and Dohme, Novartis Pharmaceuticals, Novo Nordisk and Sanofi, and honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharpe and Dohme, Novartis Pharmaceuticals, Novo Nordisk and Sanofi
This is more than a Zepbound support group website it's a growing community of real people sharing real stories and real solutions
This calculator is especially helpful when pharmacies dispense compounded tirzepatide or semaglutide in different concentrations